Disclosures. Learning Objectives. Pharmacy Law Topics. Spring Seminar 2017
|
|
- Randell Doyle
- 6 years ago
- Views:
Transcription
1 Spring Seminar 2017 prescribing authority Controlled substance Privacy Pharmacy Law Topics Charlie Mollien, PharmD, JD, MS Director of Pharmacy Compliance & Privacy Officer Meijer Disclosures Charlie Mollien has no conflicts of interest or financial interest to disclose. Activity type: knowledge-based Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Learning Objectives 1. Review the 2016 and 2017 changes to the Public Health Code and Administrative Code that change midlevel prescribing authority. 2. Discuss the Controlled Substances Act requirements for a prescriber to issue a valid controlled substance prescription and the pharmacist s corresponding responsibility. 3. Review how the Health Insurance Portability and Accountability Act permits disclosure of Protected Health Information.
2 prescribing authority prescribing authority DELEGATION PRACTICE AGREEMENT 2016 rule changes 2017 law changes prescribing authority Delegated prescribing of controlled substances before December 2016 PHYSICIAN ASSISTANT Delegation to prescribe controlled substances allowed under MD, DO, and DPM Limited scope of practice Based on delegation agreement Indicate names (and DEA numbers for controlled substances) of PA and supervising physician on controlled all PA used supervising physician s controlled substance to prescribe PA must have his or her own DEA registration number NURSE PRACTITIONER/ NURSE MIDWIFE Delegation to prescribe controlled substances allowed under MD and DO Limited scope of practice CII s may only be prescribed for patients discharged from or located within a freestanding surgical outpatient facility, hospital, or hospice CII limited to a 7-day supply NP/NMW used supervising physician s controlled substance to prescribe NP/NMW must have his or her own DEA registration number For NP/NMW delegation, see MAC r (DO), (MD). For PA delegation, see MAC r (DO), (MD), (DPM). Differences between PA and NP/NMW delegation in blue font.
3 prescribing authority MAC r Delegation of prescribing controlled substances to nurse practitioners or nurse midwives; limitation. (1) A physician may delegate the prescription of controlled substances listed in schedules 2 to 5 to a registered nurse who holds specialty certification under section of the code, MCL , with the exception of a nurse anesthetist, if the delegating physician establishes a written authorization that contains all of the following information: (a) The name, number, and signature of the delegating physician. (b) The name, number, and signature of the nurse practitioner or nurse midwife. (c) The limitations or exceptions to the delegation. (d) The effective date of the delegation. (2) A delegating physician shall review and update a written authorization on an annual basis from the original date or the date of amendment, if amended. A delegating physician shall note the review date on the written authorization. (3) The delegating physician shall ensure that an amendment to the written authorization is in compliance with subrule (1) of this rule. (4) A delegating physician shall maintain the signed, written authorization at the delegating physician s primary place of practice. (5) The delegating physician shall provide a copy of the signed, written authorization to the nurse practitioner or nurse midwife. (6) A delegating physician shall not authorize a nurse practitioner or a nurse midwife to issue a prescription for a schedule 2 controlled substance with a quantity greater than a 30-day supply. (7) A delegating physician shall not delegate the prescription of a drug or device individually, in combination, or in succession for a woman known to be pregnant with the intention of causing either a miscarriage or fetal death. Board of Osteopathic Medicine and Surgery. prescribing authority MAC r Delegation of prescribing controlled substances to nurse practitioners or nurse midwives; limitation. (1) A physician may delegate the prescription of controlled substances listed in schedules 2 to 5 to a registered nurse who holds specialty certification under section of the code, MCL , with the exception of a nurse anesthetist, if the supervising physician establishes a written authorization that contains all of the following information: (a) The name, number, and signature of the supervising physician. (b) The name, number, and signature of the nurse practitioner or nurse midwife. (c) The limitations or exceptions to the delegation. (d) The effective date of the delegation. (2) The supervising physician shall review and update a written authorization on an annual basis from the original date or the date of amendment, if amended. The supervising physician shall note the review date on the written authorization. (3) The supervising physician shall maintain a written authorization at the supervising physician s primary place of practice. (4) The supervising physician shall provide a copy of the signed, written authorization to the nurse practitioner or nurse midwife. (5) The supervising physician shall ensure that an amendment to the written authorization is in compliance with subrules (1), (2), (3), and (4) of this rule. (6) A supervising physician shall not authorize a nurse practitioner or a nurse midwife to issue a prescription for a schedule 2 controlled substance with a quantity greater than a 30-day supply. (7) A supervising physician shall not delegate the prescription of a drug or device individually, in combination, or in succession for a woman known to be pregnant with the intention of causing either a miscarriage or fetal death. Board of Medicine. prescribing authority Delegation PHYSICIAN ASSISTANT Superseded by law changing definition of practice as a physician s assistant and prescriber in the Public Health Code. NURSE PRACTITIONER/ NURSE MIDWIFE Written delegation agreement between MD and NMW, NP, or clinical nurse specialist (not nurse anesthetists) NP or NMW may not issue a schedule 2 prescription with a quantity greater than a 30-day supply. NP/NMW s may never prescribe drugs with intent to cause miscarriage or fetal death For NP/NMW delegation, see MAC r (DO), (MD). For PA delegation, see MAC r (DO), (MD), (DPM). MAC r and do not include clinical nurse specialists.
4 PHYSICIAN ASSISTANT PA s are independent prescribers. Delegation is not allowed. Must have a practice agreement with: MD to practice medicine as a PA. DO to practice osteopathic medicine and surgery as a PA. DPM to practice pediatric medicine and surgery as a PA. prescribing authority Delegation For PA s, delegation now allowed. See MCL (MD), (DO), and (DPM) for practice agreement requirements. prescribing authority Practice agreements PHYSICIAN ASSISTANT to practice as a physician assistant Written agreement between MD and PA, limited to duties and responsibilities within PA s scope of education, training, or experience LARA may restrict drugs or drug classes that a PA may not prescribe Independent prescribing authority for all medications ADVANCED PRACTICE RN to practice as an APRN Nurse midwife Nurse practitioner Clinical nurse specialist Independent prescribing authority for non-scheduled prescription drugs May prescribe controlled substances by delegation Rx must include the name and DEA number for both the APRN and supervising MD/DO For NP/NMW practice agreement, see MCL a. For PA practice agreement, see MCL (MD), (DO), and (PDM). prescribing authority current as of April 9, 2017 Prerequisites to prescribe medicine Prescriptive authority (subject to scope of practice) Dispensing issued out-of-state Controlled substance /registration Scope of practice Practice Agreement Delegation Prescribe nonscheduled (indicate supervising physician on Rx) medicine Prescribe controlled substances non-scheduled Controlled substance controlled substance DEA number MD, DO Unlimited N/A N/A Yes Yes for issued in DVM/VMD Animals N/A N/A (animals only) (animals only) Yes Yes for issued in DDS/DMD Mouth N/A N/A Yes Yes for issued in OD Eye Must have therapeutic pharmaceutical agent (TPA) certification Always required DPM Hand*, Foot, Ankle N/A N/A Always required PA Based on practice agreement N/A (based practice agreement) (based practice agreement) Always required NP, NMW, Clinical Nurse Specialist Based on practice agreement to prescribe controlled substances (based practice agreement), up to 30 days supply (must also have supervising physician s DEA number on Rx) (May use MD/DO ) *DPM scope for hands is limited to examination, diagnosis, and treatment of abnormal nails and superficial excrescenses, including warts and callosities.
5 prescribing authority current as of April 9, 2017 Scope of practice Prerequisites to prescribe medicine Practice Agreement Delegation (indicate supervising physician on Rx) Prescriptive authority (subject to scope of practice) Prescribe nonscheduled medicine Prescribe controlled substances Dispensing issued out-of-state non-scheduled Controlled substance Controlled substance /registration controlled substance DEA number MD, DO Unlimited N/A N/A Yes Yes for issued in DVM/VMD Animals N/A N/A (animals only) (animals only) Yes Yes for issued in DDS/DMD Mouth N/A N/A Yes Yes for issued in OD Eye Must have therapeutic pharmaceutical agent (TPA) certification Always required DPM Hand*, Foot, Ankle N/A N/A Always required PA Based on practice agreement N/A (based practice agreement) (based practice agreement) Always required NP, NMW, Clinical Nurse Specialist Based on practice agreement to prescribe controlled substances (based practice agreement), up to 30 days supply (must also have supervising physician s DEA number on Rx) (May use MD/DO ) *DPM scope for hands is limited to examination, diagnosis, and treatment of abnormal nails and superficial excrescenses, including warts and callosities.
6 Controlled substance DEA 161 DEA 161R DEA 236 DEA 357 DEA 189 DEA 250 DEA 488 Quotas, Imports, Exports PDMP reverse distributor DEA 106 DEA 41 DEA 222 DEA e222 DSCSA (DQSA Title II) ARCOS ARCOS Controlled substance License and registration requirements to prescribe controlled substances
7 DEA 189 DEA 250 DEA 488 (DQSA Title II) DSCSA DEA 161 DEA 161R DEA 236 DEA 357 ARCOS DEA 41 reverse distributor Quotas, Imports, Exports ARCOS DEA 106 PDMP DEA 222 DEA e222
8 License and registration requirements to prescribe controlled substances MD, DO, DDS/DMD, DPM, DVM/VMD, OD, and PHYSICIAN ASSISTANT MICHIGAN: Must obtain a controlled substance (CS) and USA: Must have an active DEA registration certificate with authority to prescribe drug schedule CII n-narcotic CII Narcotic CIII n-narcotic CIII Narcotic CIV CV ADVANCED PRACTICE RN MICHIGAN: May use MD/DO CS through delegation; must also indicate supervising physician s name and DEA number on CS USA: Must have an active DEA registration certificate with authority to prescribe drug schedule CII n-narcotic CII Narcotic CIII n-narcotic CIII Narcotic CIV CV prescriber, as defined under MCL , practicing within the state of must have a controlled substance ( MCSL ) to prescribe controlled substances. A MCSL is not required for out-of-state controlled substance issued by MD s, DO s, DDS/DMD s, and DVM/VMD s. All other out-of-state prescribers, as recognized under law, must also have a MCSL for controlled substance to be dispensed by a pharmacy in the state of. Controlled substance Anatomy of a valid prescription E. Beltline SE, Grand Rapids, MI FD Tel: (616) E 8 Owner: John Smith 7 5 Name Rascal Smith (canine) Address 1 NE Grand Rapids, MI and over Xanax 1 mg tab 14 #5 (five) Sig: 1 po daily PRN fireworks 15 Refills NR E Jane Doe, DVM 17 Jane Doe Signature 2 10 Do not fill until 6/7/17 DOB Date 9 5/9/ Prescriber s printed name (For APRN s, include supervising physician name and DEA number for CS s) Prescriber s professional designation Prescriber s address Prescriber s DEA registration number Patient s full name Patient s address, or owner s address if patient is an animal If patient is an animal, species If patient is an animal, owner s full name Date issued 10 Do not fill until date Drug name Drug strength Drug form Quantity (written Rx must have numerical and written or checked box/line quantity) Directions for use Refill indication (zero refills if not on Rx) Prescriber s signature (written) Prescriber s electronic signature (e-rx) Electronically prescribed controlled substances must also include prescriber s electronic signature, telephone number, name of pharmacy Rx sent to, date and time of transmission, and whether substitution permissible. 2 9
9 SENT TO: ABC PHARMACY #1 DATE SENT: 5/9/2017 AT 11:37:00 AM DATE WRITTEN: 5/8/2017 A8982K2I92KLSD9824 PATIENT: JOHN SMITH BIRTHDATE: 1/1/1975 ADDRESS: 1 MICHIGAN NE GRAND RAPIDS, MI DRUG: AMBIEN 5 MG TABLET QUANTITY: 30 DIRECTIONS: 1 TAB PO HS PRN, 30 MIN BEFORE DAYS SUPPLY: 30 REFILL: 0 E MAY SUBSTITUTE 10 COMMENT: DO NOT FILL UNTIL 6/5/2017 PRESCRIBER ELECTRONICALLY SIGNED BY JANE DOT, F-NP 1810 E. BELTLINE SE, GRAND RAPIDS, MI FD TEL: (616) SUPERVISING PHYSICIAN JASON WATCHDOG, MD BW TRANSMITTED BY: AGENT AMY E 1 E Prescriber s printed name (For APRN s, include supervising physician name and DEA number for CS s) Prescriber s professional designation Prescriber s address Prescriber s DEA registration number Patient s full name Patient s address, or owner s address if patient is an animal If patient is an animal, species If patient is an animal, owner s full name Date issued Drug name Drug strength Drug form Quantity (written Rx must have numerical and written or checked box/line quantity) Directions for use Refill indication (zero refills if not on Rx) Prescriber s signature (written) Prescriber s electronic signature (e-rx) 10 Do not fill until date Electronically prescribed controlled substances must also include prescriber s electronic signature, telephone number, name of pharmacy Rx sent to, and date and time of transmission. 9 Controlled substance Corresponding responsibility Controlled substance A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice. The responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription. An order purporting to be a prescription issued not in the usual course of professional treatment or in legitimate and authorized research is not a prescription within the meaning and intent of section 309 of the Act (21 U.S.C. 829) and the person knowingly filling such a purported prescription, as well as the person issuing it, shall be subject to the penalties provided for violations of the provisions of law relating to controlled substances. 21 CFR The DEA refers to the pharmacist s corresponding responsibility as the last line of defense.
10 Controlled substance RED FLAGS A red flag is a level of concern that might cause a pharmacist to either choose not to fill a prescription or take some other kind of actions and the more red flags there are, the stronger that suspicion is. A pharmacist is required to resolve red flags before dispensing the controlled substance prescription. Holiday CVS, L.L.C., d/b/a CVS/Pharmacy s. 219 and 5915; Decision and Order. FR (citing 21 CFR (a)). Controlled substance RED FLAGS Controlled substances are high alert drugs and among controlled substances, drugs such as opioids, benzodiazepines, and other central nervous system depressant drugs require the highest level of scrutiny on the part of a pharmacist who is presented with for these drugs. Simply calling a doctor's office to verify that he or she wrote a prescription does not meet the requirement [of verification]." Holiday CVS, L.L.C., d/b/a CVS/Pharmacy s. 219 and 5915; Decision and Order. FR (citing 21 CFR (a)). Controlled substance RED FLAGS Many customers: A. Receiving the same combination of ; B. Receiving the same strength of controlled substances; C. Paying cash for their ; D. With the same diagnosis codes written on their ; E. With controlled substance written by physicians not associated with pain management (i.e., pediatricians, gynecologists, ophthalmologists, etc.) Prescriptions that result in therapeutic conflicts Individuals driving long distances to visit physicians and/or to fill Customers coming to the pharmacy in groups, each with the same issued by the same physician Hill, Robert L. Drug Enforcement Administration. Prescription Drug Abuse. Available at: pharm_awareness/conf_2014/april_2014/hill.pdf#search=red%20flags. Last accessed April 22, 2017.
11 Controlled substance RED FLAGS Paying for controlled substance with cash or using discount cards Respective locations of the patient and the prescriber Prescriber writes for certain combinations or patterns of drugs Multiple patients present for the same drugs and the same quantities from the same doctor without variability (suggesting the prescribing is done in a factory like manner Combinations of drugs (e.g. alprazolam and oxycodone) because both drugs are commonly diverted Prescribing oxycodone 15 mg and 30 mg tablets together Holiday CVS, L.L.C., d/b/a CVS/Pharmacy s. 219 and 5915; Decision and Order. FR (citing 21 CFR (a)). Controlled substance RED FLAGS Evaluate each individual prescription. Don t use preset limits. The pharmacist limited the number of the store would fill each day even though the pharmacy still had oxycodone in inventory. The prescription limit was set to keep some inventory for real pain patients. The pharmacist s opinion was that "as a pharmacist she was stuck between a rock and a hard place, and that basically * * * she had not been trained to diagnose," and that if she or her staff were "able to confirm that a prescription had been issued by a physician who was d by the state, and had a DEA, then... [the pharmacy] should be able to trust that that prescription--or that physician is legitimate, and that the doctor * * * ha[d] given the correct diagnosis." Holiday CVS, L.L.C., d/b/a CVS/Pharmacy s. 219 and 5915; Decision and Order. FR (citing 21 CFR (a)). Privacy
12 M I N I M U M N E C E S S A R Y R U L E Permitted Uses and Disclosures 1. To the individual. 2. Treatment, payment, and operations. 3. Uses and disclosures with opportunity to object. 4. Incidental use and disclosure. 5. Public interest and benefit activities. 6. Limited data set. Authorized Uses and Disclosures 1. Authorization. 2. Psychotherapy notes. 3. Marketing. Uses and Disclosures 1. To the individual (or their personal representative) when requesting A. Access to PHI B. Accounting of disclosures of PHI 2. To HHS for a(n) A. Compliance investigation B. Enforcement action Controlled substance DECEASED PATIENT RECORDS HIPAA survives death PHI is protected for 50 years following death Medical records/phi of the deceased patient may be released to: Spouse, parent, child, domestic partner, other relatives or friends of decedent if that person was involved in the decedent s health care or payment for care prior to death Covered entity must continue to honor any restrictions or the disclosure is inconsistent with known prior expressed preferences Personal representative (the person with legal authority to act on behalf of the decedent or decedent s estate, such as the estate executor/ administrator or individual with health care power of attorney) Law enforcement, but only to alert individual s death if suspected cause of death is criminal conduct Coroners or medical examiners and funeral directors Research that is solely on the PHI of the decedent Organ procurement organizations that procure, bank, or transplant cadaveric organs, eyes, or tissue to facilitate organ, eye, or tissue donation and transplantation Contact information Charlie Mollien 2929 Walker Ave NW Grand Rapids, MI Charlie.Mollien@meijer.com
13 Which of the following prescribers does not require a Controlled Substance License to prescribe a schedule IV controlled substance? a. PA b. NP c. MD d. DO e. none of the above Which of the following prescribers may not enter into a practice agreement with a midlevel PA or advanced practice registered nurse? a. Ophthalmologist b. Rheumatologist c. Podiatrist d. Dermatologist e. All of the above may enter into a practice agreement In, A schedule III controlled substance prescription issued by an appropriately d advanced practice registered nurse under the supervision of a medical doctor may be issued for up to a day supply and refills. a. 7, 5 b. 7, 0 c. 30, 5 d. 30, 0 e. 90, 1
14 The widow of patient John Doe may obtain a copy of the deceased John's prescription fill history if she presents John's death certificate listing her as the spouse at the time of his death. further documentation is required. a. True b. False
10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationPharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.
Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A. Objectives: Pharmacist and Pharmacy Technician Learning Objectives: At the end of this activity, participants
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationLook WHAT They ve Done to Us: Law Update 2014 October 2014 Greg Baran B.S. Pharm., M.A., FMPA
Look WHAT They ve Done to Us: Law Update 2014 October 2014 Greg Baran B.S. Pharm., M.A., FMPA Objectives: At the completion of this program, participants will be able to: 1. Recognize the changes made
More informationNATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
More informationOpp Health and Rehabilitation, LLC 115 Paulk Avenue P.O. Box 730 Opp, AL Phone Number: (334)
Opp Health and Rehabilitation, LLC 115 Paulk Avenue P.O. Box 730 Opp, AL 36467-1695 Phone Number: (334) 493-4558 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW
More informationRULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI
RULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI This agency was created as an independent state agency
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationWAKE FOREST BAPTIST HEALTH NOTICE OF PRIVACY PRACTICES
WAKE FOREST BAPTIST HEALTH NOTICE OF PRIVACY PRACTICES Effective April 14, 2003 Revised February 17, 2010 Revised September 23, 2013 Revised July 1, 2016 This Notice of Privacy Practices applies to the
More informationAccommodate reasonable requests you may have to communicate health information by alternative means or at alternative locations.
Collom & Carney Clinic Association NOTICE OF PRIVACY PRACTICES Effective Date: April 14, 2003 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED, AND HOW YOU CAN GET ACCESS
More informationThank you for coming to our San Antonio Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Thank you for coming to our San Antonio Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The
More informationAlert. Changes to Licensed Scope of Practice of Physician s Assistants in Michigan. msms.org. Participating Physician. Practice Agreement
Alert Changes to Licensed Scope of Practice of Physician s Assistants in Michigan By Patrick J. Haddad, JD, Kerr, Russell and Weber, PLC, MSMS Legal Counsel FEBRUARY 24, 2017 Public Act 379 of 2016, effective
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationOVERVIEW OF THE USES AND DISCLOSURES OF PHI
PRIVACY 24.0 OVERVIEW OF THE USES AND DISCLOSURES OF PHI Scope: Purpose: All workforce members (employees and non-employees), including employed medical staff, management, and others who have direct or
More informationHIPAA THE PRIVACY RULE
HIPAA THE PRIVACY RULE Reviewed December 2012 HISTORY In 2000, many patients that were newly diagnosed with depression received free samples of antidepressant medications in their mail. 2 HISTORY Many
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES 1 Effective Date: April 14, 2003 Revision Date: September 23, 2013 Revision Date: January 17, 2018 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
More informationA New Scope of Practice for PAs and APRNs in Michigan
A New Scope of Practice for PAs and APRNs in Michigan State Bar of Michigan Health Care Law Section Annual Meeting, September 12, 2017 Kathleen A. Reed California Illinois Michigan Minnesota Texas Washington,
More information(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances.
ACTION: Revised DATE: 07/20/2017 4:25 PM 4729-5-30 Manner of issuance of a prescription. (A) A prescription, to be valid, must be issued for a legitimate medical purpose by an individual prescriber acting
More informationLegal Issues in Managing Opioid Abuse. Gwen Dayton, JD
Legal Issues in Managing Opioid Abuse Gwen Dayton, JD Faculty Disclosure It is the policy of the Oregon Hospice Association to insure balance, independence, objectivity, and scientific rigor in all its
More informationThe Wisconsin epdmp:
The Wisconsin epdmp: Frequently Asked Questions Pursuant to 2015 Wisconsin Act 266, effective April 1, 2017, Wisconsin-licensed physicians and other prescribers must review a patient s records from Wisconsin
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY. Who Presents this
More informationGeorgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018
Georgia DPH Prescription Title Drug Heading Monitoring Program Program Sheila Pierce April 2018 What is the PDMP? Legislative Mandates Registration Requirements How to use the PDMP Next Steps for Prescribers
More informationMassachusetts Prescription Monitoring Program
Massachusetts Prescription Monitoring Program PDMP Training and Technical Assistance Center at Brandeis University in partnership with the Bureau of Justice Assistance August 8, 2012 Massachusetts Department
More informationRULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES & CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
More informationCAPITAL SURGEONS GROUP, PLLC
CAPITAL SURGEONS GROUP, PLLC NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW
More informationPayment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:
Your Rx Pharmacy Notice of our privacy practices THIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationRECEIPT OF NOTICE OF PRIVACY PRACTICES WRITTEN ACKNOWLEDGEMENT FORM. I,, have received a copy of Dr. Andy Hand s Notice of Privacy Practice.
Central Texas Institute Of Plastic Surgery, PA Dr. Andy Hand, M.D. Plastic and Reconstructive Surgery Cosmetic Plastic Surgery RECEIPT OF NOTICE OF PRIVACY PRACTICES WRITTEN ACKNOWLEDGEMENT FORM I,, have
More informationPatient Section. Patient Name: (Last) (First) (MI) Address: City: State: Zip: Date of Birth: / / Month Day Year Home Phone: ( ) - Cell Phone: ( ) -
Lilly Cares Foundation Patient Assistance Program PO Box 13185 La Jolla, CA 92039 1-800-545-6962 Fax: (844) 431-6650 www.lillycares.com Patient Name: (Last) (First) (MI) Address: City: State: Zip: Date
More informationIf you have any questions about this notice, please contact our privacy officer Dr. Jev Sikes at
Notice of Privacy Practices For Deep Eddy Psychotherapy THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT
More informationAlert. Recognition of Advance Practice Registered Nurses by Michigan Statute. msms.org. April 2017
Alert April 2017 Recognition of Advance Practice Registered Nurses by Michigan Statute By Patrick J. Haddad, JD, Kerr, Russell and Weber, PLC, MSMS Legal Counsel Public Act 499 of 2016, effective April
More informationDEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR'S OFFICE MEDICINE - GENERAL RULES
DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR'S OFFICE MEDICINE - GENERAL RULES (By authority conferred on the director of the department of licensing and regulatory affairs by sections 16145,
More informationPrescription Monitoring Program State Profiles - Michigan
Prescription Monitoring Program State Profiles - Michigan Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationPrescription Monitoring Program State Profiles - Illinois
Prescription Monitoring Program State Profiles - Illinois Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationHH Health System-Shoals, LLC dba Helen Keller Hospital Notice of Privacy Practices
HH Health System-Shoals, LLC dba Helen Keller Hospital Notice of Privacy Practices THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION.
More informationNotice of. Privacy Practices. Dartmouth-Hitchcock Affiliated Covered Entity
Notice of Privacy Practices Dartmouth-Hitchcock Affiliated Covered Entity This Notice describes how medical information about you may be used and disclosed and how you can get access to this information.
More informationSenior Care Pharmacy Wichita
Senior Care Pharmacy Wichita 1402 S.RIDGE ROAD WICHITA, KS, 67209 Phone: 316-945-7455 Fax: 316-945-7457 Contact:- Carol Parsons Dear patient/responsible party, Effective immediately, each patient/responsible
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE
PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationPATIENT INFORMATION Please Print
PATIENT INFORMATION Please Print DATE Patient s Last Name First Name Middle Name Suffix Gender: q Male q Female Social Security Number of Birth Race Ethnic Group: q Hispanic q Non-Hispanic q Unknown Preferred
More informationSUMMARY OF NOTICE OF PRIVACY PRACTICES
LAKE REGIONAL MEDICAL GROUP 54 HOSPITAL DRIVE OSAGE BEACH, MO 65065 SUMMARY OF NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU
More informationAs Introduced. 131st General Assembly Regular Session H. B. No
131st General Assembly Regular Session H. B. No. 548 2015-2016 Representative Schuring Cosponsor: Representative Sprague A B I L L To amend sections 4723.43, 4723.44, 4729.01, and 4761.17 of the Revised
More informationBold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing
Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing 700.001: Definitions Delegate means an authorized support staff
More informationJoseph Bikowski, M.D., Associates
Joseph Bikowski, M.D., Associates BIKOWSKI SKIN CARE CENTER 500 Chadwick Street Sewickley, PA 15143 Effective Date: September 20, 2013 (revised) THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU
More informationOrthopedic Specialty Clinic, Ltd. Updated 05/2014
Orthopedic Specialty Clinic, Ltd. Updated 05/2014 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationNotice of Privacy Practices
Notice of Privacy Practices This notice describes how medical information about you may be used and disclosed, and how you can get access to this information. Please review it carefully. Our commitment
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES Effective Date: April 14, 2003 Revised: September 23, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board
More informationMSK Group, PC NOTICE O F PRIVACY PRACTICES Effective Date: December 30, 2015
MSK Group, PC NOTICE O F PRIVACY PRACTICES Effective Date: December 30, 2015 This notice describes how medical information about you may be used and disclosed and how you can get access to this information.
More informationPARAGOULD DOCTORS CLINIC PRIVACY NOTICE
PARAGOULD DOCTORS CLINIC PRIVACY NOTICE Protected Health Information THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE
More informationHIPAA Notice of Privacy Practices
HIPAA Notice of Privacy Practices Georgia Mountains Hospice understands that your health information is highly personal and we are committed to safeguarding your privacy. Please read this Notice of Privacy
More information2015 Annual Convention
2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 9:45 am 11:15 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 10 Title: Activity Type: Speaker: How to Be
More informationNOTICE OF PRIVACY PRACTICES
Our Responsibilities Notice of Privacy Practices - Page 1 NOTICE OF PRIVACY PRACTICES Our Responsibilities. Your Information. Your Rights. This Notice of Privacy Practices ( Notice ) explains how University
More informationPrivacy Rio Grande Valley HIE Policy: P1. Last date Revised/Updated 02/18/2016
Privacy Rio Grande Valley HIE Policy: P1 Effective Date 01/15/2014 Last date Revised/Updated 02/18/2016 Date Board Approved: 02/18/2016 Subject: Authorization to Use and/or Disclose Protected Health Information
More informationPatient Section All fields are required. Please print clearly and complete all information.
Lilly Cares Foundation Patient Assistance Program PO Box 13185 La Jolla, CA 92039 Phone: 1-800-545-6962 Fax: 1-844-431-6650 www.lillycares.com Patient Section All fields are required. Please print clearly
More informationBalance Fitness and Nutrition
Balance Fitness and Nutrition HIPPA Notice of Privacy Practices Effective Date: January 29, 2012 THIS NOTICE DESCRIBES HOW PROTECTED HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN
More informationPatient Privacy Requirements Beyond HIPAA
Patient Privacy Requirements Beyond HIPAA Jane Hyatt Thorpe, J.D. School of Public Health and Health Services George Washington University Carrie Bill, J.D. Feldesman Tucker Leifer Fidell LLP The George
More informationPrivacy Practices Home Visit Doctor, LLC July 2017
Privacy Practices Home Visit Doctor, LLC July 2017 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationDistrict of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
More informationThis notice describes Florida Hospital DeLand s practices and that of: All departments and units of Florida Hospital DeLand.
MRN: FIN: FLORIDA HOSPITAL DELAND HIPAA NOTICE OF PRIVACY PRACTICES Effective Date: September 23, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN
More informationTECHNICIAN LAW REVIEW. Objectives. Outline 9/20/2012
TECHNICIAN LAW REVIEW Morganne Smyth, Pharm.D. Pharmacy Practice Resident St. Luke s Health System - Boise ISHP 2012 Fall Meeting Objectives At the conclusion of this presentation, the audience should
More informationHIPAA Notice of Privacy Practices
HIPAA Notice of Privacy Practices *HIPAA: Health Insurance Portability and Accountability Act Effective Date: April 14, 2003; rev. Dec. 1, 2003; Form # 030463 CAT: 15-Patient Data To reorder, log onto
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES 1 Effective Date: April 14, 2003 Revised: September 23, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO
More informationOUR LEGAL DUTY PERSONS COVERED BY THIS NOTICE
Dermatology Associates of Atlanta, P.C. Dermatology & Skin Cancer Center Atlanta Laser & Cosmetic Surgery Center Griffin Center for Hair Restoration & Research Laser Institute of Georgia Skin Medics Medical
More informationMURRAY MEDICAL CENTER HIPAA NOTICE OF PRIVACY PRACTICES
CW CR 618 Exhibit A MURRAY MEDICAL CENTER HIPAA NOTICE OF PRIVACY PRACTICES Effective Date: THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS
More informationMichigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS
Michigan PDMP name: MAPS PDMP region: Agency responsible: Bureau of Professional Licensing, Drug Monitoring Section Agency type: Professional Licensing Agency PDMP email: BPL-MAPS@michigan.gov PDMP website:
More informationNEW BRIGHTON CARE CENTER
NEW BRIGHTON CARE CENTER 805 6 th Ave NW, New Brighton, MN 55112 NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS
More informationYour Medical Record Rights in i Maryland
Your Medical Record Rights in i Maryland (A Guide to Consumer Rights under HIPAA) JOY PRITTS, JD NINA L. KUDSZUS HEALTH POLICY INSTITUTE GEORGETOWN UNIVERSITY Your Medical Record Rights in Maryland (A
More informationYour Medical Record Rights in Rhode Isl and
Your Medical Record Rights in Rhode Isl and (A Guide to Consumer Rights under HIPAA) JOY PRITTS, JD MARISA GUEVARA HEALTH POLICY INSTITUTE GEORGETOWN UNIVERSITY Your Medical Record Rights in Rhode Island
More informationCHI Mercy Health. Definitions
CHI Mercy Health Definitions If you have any questions about this notice, please contact the CHI Mercy Health s Privacy Office at (701) 845-6540 or 570 Chautauqua Blvd, Valley City ND 58072. Notice of
More informationAlaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP
Statistics website: Carrillo, Laura - PDMP Manager 550 W. 7th Ave, Ste 1500 Anchorage AK 99501 Office: (907) 269-8404 Fax: (907) 465-2974 Email: laura.carrillo@alaska.gov Alaska PDMP name: AKPDMP PDMP
More informationREVISED NOTICE OF PRIVACY PRACTICES ORIGINAL DATE: JANUARY 1, 2003 REVISED: JANUARY 16, 2014 REVISED: NOVEMBER 27, 2017 PLEASE REVIEW IT CAREFULLY
REVISED NOTICE OF PRIVACY PRACTICES ORIGINAL DATE: JANUARY 1, 2003 REVISED: JANUARY 16, 2014 REVISED: NOVEMBER 27, 2017 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
More informationPractice Limited to Infants, Children, & Adolescents
Practice Limited to Infants, Children, & Adolescents 9290 SE Sunnybrook Blvd., #200, Clackamas, OR 97015 (503) 659-1694 5050 NE Hoyt St., #B55, Portland, Oregon 97213 (503) 233-5393 16144 SE Happy Valley
More informationNew Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP
Statistics website: Ryba, Peter, PharmD - PMP Director 5500 San Antonio Drive NE, Suite C Albuquerque NM 87109 Office: (505) 222-9818 Fax: (505) 222-9845 Email: peter.ryba@state.nm.us New Mexico PDMP name:
More informationNebraska Pharmacy Law 2015
CPE Session 11 Nebraska Pharmacy Law Saturday, April 25, 2015 ACPE UAN 0128-0000-15-032-L03-P and 0128-0000-15-032-L03-T 1.0 CPE Hour Joni Cover, JD Joni Cover graduated with a Bachelor of Arts in Communications
More informationHIPAA PRIVACY TRAINING
HIPAA PRIVACY TRAINING HIPAA Privacy Training Objective Present a general overview of HIPAA and define important terms Understand the purpose of HIPAA and the Privacy Rule Understand the term Protected
More informationChapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory)
Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory) By: Katie Blair, PharmD, RPh Author Disclosure: Katie Blair and Elite Professional Education, LLC do not have any actual or potential
More informationNotice of HIPAA Privacy Practices Updates
Notice of HIPAA Privacy Practices Updates The following is a summary of the updates to the privacy notice for Meridian Hospitals Corporation, Meridian Home Care Services, Inc., Meridian Nursing & Rehabilitation,
More informationYour Medical Record Rights in Hawaii
Your Medical Record Rights in Hawaii (A Guide to Consumer Rights under HIPAA) JOY PRITTS, JD MARISA GUEVARA HEALTH POLICY INSTITUTE GEORGETOWN UNIVERSITY Your Medical Record Rights in Hawaii (A Guide to
More informationYour Medical Record Rights in Wisconsin
Your Medical Record Rights in Wisconsin (A Guide to Consumer Rights under HIPAA) JOY PRITTS, JD NINA L. KUDSZUS HEALTH POLICY INSTITUTE GEORGETOWN UNIVERSITY Your Medical Record Rights in Wisconsin (A
More informationphysicians, nurses, and technicians and other Facility personnel for review and learning purposes. We may also combine the medical information we
WESTMINSTER CANTERBURY - RICHMOND NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW
More informationNEW MEXICO PRACTITIONER S MANUAL
NEW MEXICO PRACTITIONER S MANUAL An Informational Outline From the New Mexico Board of Pharmacy 5200 Oakland NE Suite A Albuquerque, New Mexico 87113 505-222-9830 800-565-9102 E-Mail: Debra.wilhite@state.nm.us
More informationERIE COUNTY MEDICAL CENTER CORPORATION NOTICE OF PRIVACY PRACTICES. Effective Date : April 14, 2003 Revised: August 22, 2016
ERIE COUNTY MEDICAL CENTER CORPORATION NOTICE OF PRIVACY PRACTICES Effective Date : April 14, 2003 Revised: August 22, 2016 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
More informationJOINT NOTICE OF PRIVACY PRACTICES
JOINT NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED, AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY. respects
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More informationAshe Memorial Hospital, Inc. 200 Hospital Avenue, Jefferson, NC (336) JOINT NOTICE OF PRIVACY PRACTICES
Ashe Memorial Hospital, Inc. 200 Hospital Avenue, Jefferson, NC 28640 (336) 846-7101 JOINT NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED
More informationPrescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups
Prescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups Richard Deyo, MD, MPH Depts. of Family Medicine & Internal Medicine, Oregon Health & Science University Jessica Irvine, MS Acumentra
More information(A Guide to Consumer Rights under HIPAA)
Your Medical Record Rights in Delaware (A Guide to Consumer Rights under HIPAA) JOY PRITTS, JD MARISA GUEVARA HEALTH POLICY INSTITUTE GEORGETOWN UNIVERSITY Your Medical Record Rights in Delaware (A Guide
More informationJ.C. Blair Memorial Hospital Huntingdon, PA
J.C. Blair Memorial Hospital Huntingdon, PA Notice of Privacy Practices Effective Date: 4/14/03 Revised Date: 1/21/14 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND
More informationNOTICE OF PRIVACY PRACTICES
NOTICE OF PRIVACY PRACTICES Ihosvani Miguel, MD, PA DBA: Endo Care of South Florida 1400 S Andrews Avenue Fort Lauderdale, FL 33316 Effective Date: April 2, 2013 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION
More informationYour Medical Record Rights in Louisiana
Your Medical Record Rights in Louisiana (A Guide to Consumer Rights under HIPAA) JOY PRITTS, JD MARISA GUEVARA HEALTH POLICY INSTITUTE GEORGETOWN UNIVERSITY Your Medical Record Rights in Louisiana (A Guide
More informationNeedyMeds
NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
More informationOhio. Contact Information. State Registrant Totals and Population
PDMP name: OARRS Agency responsible: State of Ohio Board of Pharmacy Agency type: Pharmacy Board PDMP email: info@pharmacy.ohio.gov PDMP website: www.ohiopmp.gov Enrollment website: https://ohio.pmpaware.net
More informationFrequently Asked Questions MN Prescription Monitoring Program (PMP)
Frequently Asked Questions MN Prescription Monitoring Program (PMP) Topics: 1. Purpose of the PMP 2. Reporting/Frequency of Reporting 3. Dispensing for Animals 4. Inappropriate Prescribing 5. Accessing
More informationMedication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives
Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting Objectives Discuss: Learn about signs of potential diversion and recognize an impaired healthcare provider. Help to identify
More informationHIPAA NOTICE OF PRIVACY PRACTICES
JULIE A THOMAS, M.D. NEDRA L RICE, M.D. SHAHEEN K. JACOB, M.D. MARY ANN FRANKEN, M.D. MAHNAZ MOSTOFI, WHNP HIPAA NOTICE OF PRIVACY PRACTICES As Required by the Privacy Regulations Created as a Result of
More informationForm B - For those enrolled in other insurance
Form B - For those enrolled in other insurance PATIENT REGISTRATION Please print clearly so that we can process your information quickly and efficiently. Thank you! Name (First, M.I., Last) Date of Birth
More informationPharmacy Welcome and Information Packet
Pharmacy Welcome and Information Packet Version date: 04/26/2017 1 Table of Contents: Pharmacy Information page 3 New patient Checklist and Timeline page 4 Order and delivery policies page 5 Repackaging
More informationAMENDMENT TO SENATE BILL 772. AMENDMENT NO.. Amend Senate Bill 772, AS AMENDED, by. replacing everything after the enacting clause with the following:
*LRB00RLC00a* Rep. Cynthia Soto Filed: //0 000SB0ham00 LRB0 0 RLC 00 a AMENDMENT TO SENATE BILL AMENDMENT NO.. Amend Senate Bill, AS AMENDED, by replacing everything after the enacting clause with the
More informationUSE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION WITHOUT AUTHORIZATION
USE AND DISCLOSURE OF PROTECTED HEALTH INFORMATION WITHOUT AUTHORIZATION Policy The Health Science Center may disclose protected health information without a patient authorization in the following circumstances:
More informationPRIVACY POLICY USES AND DISCLOSURES FOR TREATMENT, PAYMENT, AND HEALTH CARE OPERATIONS
PRIVACY POLICY As of April 14, 2003, the Federal regulation on patient information privacy, known as the Health Insurance Portability and Accountability Act (HIPAA), requires that we provide (in writing)
More informationNotice of Health Information Privacy Practices Acknowledgement
I understand that as part of my healthcare, Sonoma Valley Hospital and its medical staff creates, receives and maintains health records describing my health history, symptoms, examination and test results,
More information